dr. monk on bevacizumab in recurrent cervical cancer
Published 10 years ago • 381 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
0:59
dr. monk discusses the role of bevacizumab in metastatic cervical cancer
-
1:07
monk: dr. monk on the significance of bevacizumab in cervical cancer
-
1:53
dr. monk on the role of bevacizumab in treatment of metastatic cervical cancer
-
1:47
dr. monk on the utility of bevacizumab for cervical cancer
-
1:14
dr. tewari on the next steps for bevacizumab in recurrent cervical cancer
-
4:00
bevacizumab in advanced cervical cancer
-
0:57
dr. monk on the utility of tisotumab vedotin in recurrent cervical cancer
-
6:12
metastatic and recurrent cervical cancer treatment
-
0:55
dr. monk on the mechanism of action of tisotumab vedotin in recurrent cervical cancer
-
1:11
dr. monk on emerging therapies in cervical cancer
-
2:26
dr. monk on bevacizumab plus a vda in ovarian, tubal, or peritoneal carcinoma
-
1:04
dr. monk on the fda approval of pembrolizumab in cervical cancer
-
1:06
dr. krishnansu tewari on bevacizumab in advanced cervical cancer
-
4:54
bevacizumab in recurrent ovarian cancer
-
1:11
dr. leath on challenges with bevacizumab in cervical cancer
-
2:40
bevacizumab plus chemotherapy extends cervical cancer survival
-
0:53
dr. monk on combination therapies in patients with ovarian cancer
-
1:15
dr. monk on immunotherapy for gynecologic cancer
-
8:52
frontline therapies for metastatic cervical cancer